Insights

Learn how the Fifth Circuit's ruling on SECA exclusion for state law limited partners affects the testing of active or passive investor determination.

Discover why data capture is essential for ASU 2023-09 compliance and the technology solutions businesses can leverage to start the process now.

Explore key updates from the January 2026 tax policy review, including government funding progress, new tax reform guidance, IRS changes and global negotiations.

Explore new regulations and best practices employers should know about the OBBBA's increased compensation reporting for qualified tips and overtime.

Review key Q3 2025 SALT updates and uncover practical insights to navigate compliance, planning and alignment with shifting state and local tax policies.

Explore our exit stage guide for life science companies and uncover key strategies for successfully navigating the final phase of the startup lifecycle.

Explore our guide for multinational businesses navigating OBBBA international tax changes and their implications for 2025 filing and 2026 planning.

Explore key updates from the December 2025 tax policy review, including major 2025 milestones, expectations for 2026 and new tax reform guidance.

The clinical stage of drug development involves navigating the phases of clinical trials and fundraising to support them. Explore our guide for startups.